首页 › 基金 › Avala Global LP › INSM

Avala Global LP 对 INSM 的持仓历史

INSMED INC · 医疗保健

Avala Global LP 在 Q3 2026 的 13F 申报中披露持有 INSM(INSMED INC)321,100 股,市值约 US$36.7M,约占其申报组合的 1.20%,在其申报持仓中市值排名第 28 位。 Avala Global LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)321.10K 股
申报持仓市值$36.65M
组合权重1.20%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Avala Global LP 对 INSM 的持仓演变

Avala Global LP 于 Q3 2026 首次披露 INSM 持仓:321,100 股(约 US$36.7M)。

逐季持仓明细

季度股数金额变化
Q3 2026 321.10K $36.65M 新进

关于 INSM 与 13F 数据

INSM(INSMED INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 INSM,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$1.00B), Orbis Allan Gray Ltd (US$768.6M), Artisan Partners Limited Partnership (US$636.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 INSM 的基金

查看 INSM 的全部基金持有人 →

常见问题

How long has Avala Global LP held INSM?

Avala Global LP has disclosed INSM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Avala Global LP's current position in INSM?

As of Q3 2026, Avala Global LP holds 321.10K shares of INSM (INSMED INC), valued at $36.65M, representing 1.20% of its reported portfolio and ranking #28.

Has Avala Global LP been buying or selling INSM?

In the latest 13F filing (Q3 2026), Avala Global LP newly opened its position in INSM.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Orbis Allan Gray Ltd, Artisan Partners Limited Partnership, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.